Top

Arch Biopartners Inc.

TSXV Exchange | Nov 21, 2019, 10:02 AM EST | Real-time price

ARCH $ 0.91 RT
CHANGE
000 (000%)
VOLUME
0
Day Low: N/A
Day High: N/A
Detailed Quote
Open: N/A
High: N/A
Beta: 0.152
Shares Out.: 59,062,302
Total Shares (All Classes)2: 58,912,302
Prev. Close: 0.91
Low: N/A
VWAP: N/A
Market Cap1: 53,746,695
Market Cap (All Classes)2*: 53,610,195
Dividend: N/A
Div. Frequency: N/A
P/E Ratio: N/A
Listed Shares Out.1: 59,062,302
EPS: -0.04
Yield: N/A
Ex-Div Date: N/A
P/B Ratio: -22.75
Escrow Shares: 0
Exchange: TSXV

(1) Number based only on listed classes of shares.

(2) Number sourced from third party data provider. For the most up to date information, please refer to the company's financial documents.

*Market Capitalization is based on Total Shares Outstanding for all share classes for the company. Convertible bonds and employee stock options that would otherwise be included in the Diluted Shares amount included in a company's filings/financials are not included.

Description

Arch Biopartners Inc is a portfolio based biotechnology company. It focuses on the development of innovative technologies. The company's portfolio of technology includes AB569 which is a new drug candidate for treating antibiotic-resistant bacterial infections, primarily in the lungs and urinary tract; MetaBlok which is a new drug candidate targeting sepsis, cancer metastasis and inflammation based diseases; Arch Inflammation which is a novel treatment for chronic kidney and bowel diseases cause... More

Info TSX Venture

A comprehensive database of information on TSX Venture issuers

Show all links
Last 25 Trades
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. View delay times for all exchanges. Market Data powered by QuoteMedia, Fundamentals by Morningstar. See the QuoteMedia Terms of Use.